To increase the success of IVF, hire an artificial embryologist


To increase the success of IVF, hire an artificial embryologist

One in six couples experience infertility, which is a global health problem. Unfortunately, universal healthcare frequently does not cover treatment, and for many, the cost is too high. Even in situations where these financial obstacles can be overcome, success rates have stalled at about 33%, which means that just one-third of all treatments result in fertilisation.

Deirdre Zander-Fox, regional scientific director of Monash IVF and a knowledgeable clinician, stated that "success rates are appearing to plateau, which is likely due to a large number of factors, including increased maternal age at the time of first pregnancy, which has significant impacts on the quality of eggs, contribution of increasing patient BMI (both male and female), as well as challenges in the technology space".

The inability to distinguish "good quality" sperm, a crucial deciding element for usage in the treatment cycle, contributes to the issue. "At present, scientists choose sperm and embryos depending on how they appear under a microscope at defined discrete timepoints," said Zander-Fox. It is hoped that new research and scientific advancements would increase the success rates of ART in conceiving and giving birth to live children.

In order to choose a candidate for injection into the oocyte during assisted reproduction cycles, the shape of the sperm head has been demonstrated to correlate with other sperm quality parameters. Despite improvements in tools and technology, an embryologist's judgement ultimately governs the matter. The fact that this is a highly manual and subjective procedure and that there are discrepancies across clinics that teach different identification techniques as well as people who use their own tactics and shortcuts results in relatively low success rates.

According to Reza Nosrati, a researcher at Monash University, "I think embryologists are doing their best and taking the hit for this, but there is not enough technology available to them that can allow them to standardise and automate this procedure."

Nosrati suggests that a substitute for a human embryologist could be an artificial one, automating and standardising the process entirely. Since deep learning algorithms can self-train and recognise complicated patterns with little subjectivity, they could simplify the classification of sperm. These "virtual embryologists" could give sperm analysis and selection a global, unchanging frame of reference.

To do this, Nosrati and his group at Monash University developed an ensemble learning technique for identifying microscope images of human sperm cells as an embryologist would. The journal Advanced Intelligent Systems has published a report on its findings.

Zander-Fox, who was not involved in the study, expressed his interest in the application of AI and machine learning to evaluate sperm. We are aware of the issue with the current inter- and intra-operator variability in this area, as well as the limitations of the human sight. The pace of the processes would increase, and hopefully, the quality of the embryos we produce for treatment as well, if there was a method to apply AI and machine learning to help in the selection of the best sperm to use for insemination.

Their model's use of an "ensembled approach," which employs many learning algorithms in place of just one to improve predicted performance, distinguishes it from others.

A group of online embryologists

Four independent picture classification models, known as convolutional neural networks (CNNs), were trained separately in the study to create four virtual embryologists who were experts in the classification of sperm heads.

Because each model has a unique internal structure and the training procedure is random, each model learns a unique link between the cell picture and the shape categorization. As a result, they gain a slightly different comprehension of the sperm morphology and slightly different positive qualities of the sperm cells.

The purpose of our effort, according to Nosrati, is to transform the current platform into an automated system that can mark sperm cells in real-time and is connected to the system utilised by embryologists during an ART cycle. Hopefully, the embryologist can choose a better sperm for injection by choosing one of the sperm cells that have a better likelihood of fertilising the egg by using the real-time platform to highlight them.

This approach, which classifies each cell using a collection of algorithms, is comparable to a team of experienced physicians, each bringing their own set of experiences, viewpoints, and views, working together to categorise each cell. A meta-model, which serves as a supervisor for the four base models by ingesting highly informed and distilled information from many sources and making an executive decision, can then be utilised to intelligently leverage the findings.

Although a positive move, there are still challenges to be solved. The platform needs to be improved in order to label and evaluate the entire sperm rather than just the head, as well as to take other crucial factors like sperm motility and DNA integrity into account, according to Nosrati.

This work indicates a chance to better leverage machine learning's capabilities to provide more effective clinical treatments. Experts still remain a viable option, though.

Although AI and machine learning will play a big part in medicine in the future, there are concerns about the lack of transparency as to how the AI/machine learning model was created and what inputs were used, which needs to be addressed to ensure that medical and scientific experts trust in these systems," said Zander-Fox. Also, to be mentioned is the fact that these tools were created to support scientists and clinicians in their decision-making and should not be utilised in place of the knowledge that scientific medical experts contribute. We cannot guarantee the best patient outcomes without a partnership between AI/machine learning and professionals.

According to the research team, their findings can be used in any field where machine learning is used, not simply sperm categorization or even picture recognition tasks. The group must first solidify their existing platform, though, before that.

In three to five years, a beta prototype should be ready, according to Nosrati. "In partnership with fertility clinics, we have already begun testing this platform. We require the best training data set in order to obtain the best algorithm. The approach should be guided not just by measurements of sperm quality but also by the actual result: a live birth.

Previous Post Next Post